Table of Content

1 Gammaretroviral Vector Market Overview
1.1 Product Overview and Scope of Gammaretroviral Vector
1.2 Gammaretroviral Vector Segment by Type
1.2.1 Global Gammaretroviral Vector Market Value Comparison by Type (2024-2034)
1.2.2 Lentiviral Vectors
1.2.3 Adenoviral Vectors
1.2.4 Adeno-Associated Viral Vectors
1.2.5 Other
1.3 Gammaretroviral Vector Segment by Application
1.3.1 Global Gammaretroviral Vector Market Value by Application: (2024-2034)
1.3.2 Gene Therapy
1.3.3 Vaccinology
1.3.4 Other
1.4 Global Gammaretroviral Vector Market Size Estimates and Forecasts
1.4.1 Global Gammaretroviral Vector Revenue 2018-2029
1.4.2 Global Gammaretroviral Vector Sales 2018-2029
1.4.3 Global Gammaretroviral Vector Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Gammaretroviral Vector Market Competition by Manufacturers
2.1 Global Gammaretroviral Vector Sales Market Share by Manufacturers (2018-2024)
2.2 Global Gammaretroviral Vector Revenue Market Share by Manufacturers (2018-2024)
2.3 Global Gammaretroviral Vector Average Price by Manufacturers (2018-2024)
2.4 Global Gammaretroviral Vector Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of Gammaretroviral Vector, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Gammaretroviral Vector, Product Type & Application
2.7 Gammaretroviral Vector Market Competitive Situation and Trends
2.7.1 Gammaretroviral Vector Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Gammaretroviral Vector Players Market Share by Revenue
2.7.3 Global Gammaretroviral Vector Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Gammaretroviral Vector Retrospective Market Scenario by Region
3.1 Global Gammaretroviral Vector Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Gammaretroviral Vector Global Gammaretroviral Vector Sales by Region: 2018-2029
3.2.1 Global Gammaretroviral Vector Sales by Region: 2018-2024
3.2.2 Global Gammaretroviral Vector Sales by Region: 2024-2029
3.3 Global Gammaretroviral Vector Global Gammaretroviral Vector Revenue by Region: 2018-2029
3.3.1 Global Gammaretroviral Vector Revenue by Region: 2018-2024
3.3.2 Global Gammaretroviral Vector Revenue by Region: 2024-2029
3.4 North America Gammaretroviral Vector Market Facts & Figures by Country
3.4.1 North America Gammaretroviral Vector Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Gammaretroviral Vector Sales by Country (2018-2029)
3.4.3 North America Gammaretroviral Vector Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Gammaretroviral Vector Market Facts & Figures by Country
3.5.1 Europe Gammaretroviral Vector Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Gammaretroviral Vector Sales by Country (2018-2029)
3.5.3 Europe Gammaretroviral Vector Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Gammaretroviral Vector Market Facts & Figures by Country
3.6.1 Asia Pacific Gammaretroviral Vector Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Gammaretroviral Vector Sales by Country (2018-2029)
3.6.3 Asia Pacific Gammaretroviral Vector Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Gammaretroviral Vector Market Facts & Figures by Country
3.7.1 Latin America Gammaretroviral Vector Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Gammaretroviral Vector Sales by Country (2018-2029)
3.7.3 Latin America Gammaretroviral Vector Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Gammaretroviral Vector Market Facts & Figures by Country
3.8.1 Middle East and Africa Gammaretroviral Vector Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Gammaretroviral Vector Sales by Country (2018-2029)
3.8.3 Middle East and Africa Gammaretroviral Vector Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Gammaretroviral Vector Sales by Type (2018-2029)
4.1.1 Global Gammaretroviral Vector Sales by Type (2018-2024)
4.1.2 Global Gammaretroviral Vector Sales by Type (2024-2029)
4.1.3 Global Gammaretroviral Vector Sales Market Share by Type (2018-2029)
4.2 Global Gammaretroviral Vector Revenue by Type (2018-2029)
4.2.1 Global Gammaretroviral Vector Revenue by Type (2018-2024)
4.2.2 Global Gammaretroviral Vector Revenue by Type (2024-2029)
4.2.3 Global Gammaretroviral Vector Revenue Market Share by Type (2018-2029)
4.3 Global Gammaretroviral Vector Price by Type (2018-2029)
5 Segment by Application
5.1 Global Gammaretroviral Vector Sales by Application (2018-2029)
5.1.1 Global Gammaretroviral Vector Sales by Application (2018-2024)
5.1.2 Global Gammaretroviral Vector Sales by Application (2024-2029)
5.1.3 Global Gammaretroviral Vector Sales Market Share by Application (2018-2029)
5.2 Global Gammaretroviral Vector Revenue by Application (2018-2029)
5.2.1 Global Gammaretroviral Vector Revenue by Application (2018-2024)
5.2.2 Global Gammaretroviral Vector Revenue by Application (2024-2029)
5.2.3 Global Gammaretroviral Vector Revenue Market Share by Application (2018-2029)
5.3 Global Gammaretroviral Vector Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Novasep
6.1.1 Novasep Corporation Information
6.1.2 Novasep Description and Business Overview
6.1.3 Novasep Gammaretroviral Vector Sales, Revenue and Gross Margin (2018-2024)
6.1.4 Novasep Gammaretroviral Vector Product Portfolio
6.1.5 Novasep Recent Developments/Updates
6.2 MerckKGaA
6.2.1 MerckKGaA Corporation Information
6.2.2 MerckKGaA Description and Business Overview
6.2.3 MerckKGaA Gammaretroviral Vector Sales, Revenue and Gross Margin (2018-2024)
6.2.4 MerckKGaA Gammaretroviral Vector Product Portfolio
6.2.5 MerckKGaA Recent Developments/Updates
6.3 Charles River Laboratories
6.3.1 Charles River Laboratories Corporation Information
6.3.2 Charles River Laboratories Description and Business Overview
6.3.3 Charles River Laboratories Gammaretroviral Vector Sales, Revenue and Gross Margin (2018-2024)
6.3.4 Charles River Laboratories Gammaretroviral Vector Product Portfolio
6.3.5 Charles River Laboratories Recent Developments/Updates
6.4 UniQure N.V.
6.4.1 UniQure N.V. Corporation Information
6.4.2 UniQure N.V. Description and Business Overview
6.4.3 UniQure N.V. Gammaretroviral Vector Sales, Revenue and Gross Margin (2018-2024)
6.4.4 UniQure N.V. Gammaretroviral Vector Product Portfolio
6.4.5 UniQure N.V. Recent Developments/Updates
6.5 Waisman Biomanufacturing
6.5.1 Waisman Biomanufacturing Corporation Information
6.5.2 Waisman Biomanufacturing Description and Business Overview
6.5.3 Waisman Biomanufacturing Gammaretroviral Vector Sales, Revenue and Gross Margin (2018-2024)
6.5.4 Waisman Biomanufacturing Gammaretroviral Vector Product Portfolio
6.5.5 Waisman Biomanufacturing Recent Developments/Updates
6.6 Creative-Biogene
6.6.1 Creative-Biogene Corporation Information
6.6.2 Creative-Biogene Description and Business Overview
6.6.3 Creative-Biogene Gammaretroviral Vector Sales, Revenue and Gross Margin (2018-2024)
6.6.4 Creative-Biogene Gammaretroviral Vector Product Portfolio
6.6.5 Creative-Biogene Recent Developments/Updates
6.7 Aldevron
6.6.1 Aldevron Corporation Information
6.6.2 Aldevron Description and Business Overview
6.6.3 Aldevron Gammaretroviral Vector Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Aldevron Gammaretroviral Vector Product Portfolio
6.7.5 Aldevron Recent Developments/Updates
6.8 Addgene
6.8.1 Addgene Corporation Information
6.8.2 Addgene Description and Business Overview
6.8.3 Addgene Gammaretroviral Vector Sales, Revenue and Gross Margin (2018-2024)
6.8.4 Addgene Gammaretroviral Vector Product Portfolio
6.8.5 Addgene Recent Developments/Updates
6.9 Oxford Biomedica
6.9.1 Oxford Biomedica Corporation Information
6.9.2 Oxford Biomedica Description and Business Overview
6.9.3 Oxford Biomedica Gammaretroviral Vector Sales, Revenue and Gross Margin (2018-2024)
6.9.4 Oxford Biomedica Gammaretroviral Vector Product Portfolio
6.9.5 Oxford Biomedica Recent Developments/Updates
6.10 Thermo Fisher Scientific Inc.
6.10.1 Thermo Fisher Scientific Inc. Corporation Information
6.10.2 Thermo Fisher Scientific Inc. Description and Business Overview
6.10.3 Thermo Fisher Scientific Inc. Gammaretroviral Vector Sales, Revenue and Gross Margin (2018-2024)
6.10.4 Thermo Fisher Scientific Inc. Gammaretroviral Vector Product Portfolio
6.10.5 Thermo Fisher Scientific Inc. Recent Developments/Updates
6.11 Fujifilm Corporation
6.11.1 Fujifilm Corporation Corporation Information
6.11.2 Fujifilm Corporation Gammaretroviral Vector Description and Business Overview
6.11.3 Fujifilm Corporation Gammaretroviral Vector Sales, Revenue and Gross Margin (2018-2024)
6.11.4 Fujifilm Corporation Gammaretroviral Vector Product Portfolio
6.11.5 Fujifilm Corporation Recent Developments/Updates
6.12 Spark Therapeutics Inc
6.12.1 Spark Therapeutics Inc Corporation Information
6.12.2 Spark Therapeutics Inc Gammaretroviral Vector Description and Business Overview
6.12.3 Spark Therapeutics Inc Gammaretroviral Vector Sales, Revenue and Gross Margin (2018-2024)
6.12.4 Spark Therapeutics Inc Gammaretroviral Vector Product Portfolio
6.12.5 Spark Therapeutics Inc Recent Developments/Updates
6.13 ABL Inc
6.13.1 ABL Inc Corporation Information
6.13.2 ABL Inc Gammaretroviral Vector Description and Business Overview
6.13.3 ABL Inc Gammaretroviral Vector Sales, Revenue and Gross Margin (2018-2024)
6.13.4 ABL Inc Gammaretroviral Vector Product Portfolio
6.13.5 ABL Inc Recent Developments/Updates
6.14 Boehringer Ingelheim International GmbH
6.14.1 Boehringer Ingelheim International GmbH Corporation Information
6.14.2 Boehringer Ingelheim International GmbH Gammaretroviral Vector Description and Business Overview
6.14.3 Boehringer Ingelheim International GmbH Gammaretroviral Vector Sales, Revenue and Gross Margin (2018-2024)
6.14.4 Boehringer Ingelheim International GmbH Gammaretroviral Vector Product Portfolio
6.14.5 Boehringer Ingelheim International GmbH Recent Developments/Updates
6.15 Brammer Bio
6.15.1 Brammer Bio Corporation Information
6.15.2 Brammer Bio Gammaretroviral Vector Description and Business Overview
6.15.3 Brammer Bio Gammaretroviral Vector Sales, Revenue and Gross Margin (2018-2024)
6.15.4 Brammer Bio Gammaretroviral Vector Product Portfolio
6.15.5 Brammer Bio Recent Developments/Updates
6.16 Creative Biogene
6.16.1 Creative Biogene Corporation Information
6.16.2 Creative Biogene Gammaretroviral Vector Description and Business Overview
6.16.3 Creative Biogene Gammaretroviral Vector Sales, Revenue and Gross Margin (2018-2024)
6.16.4 Creative Biogene Gammaretroviral Vector Product Portfolio
6.16.5 Creative Biogene Recent Developments/Updates
6.17 General Electric
6.17.1 General Electric Corporation Information
6.17.2 General Electric Gammaretroviral Vector Description and Business Overview
6.17.3 General Electric Gammaretroviral Vector Sales, Revenue and Gross Margin (2018-2024)
6.17.4 General Electric Gammaretroviral Vector Product Portfolio
6.17.5 General Electric Recent Developments/Updates
6.18 Pfizer Inc
6.18.1 Pfizer Inc Corporation Information
6.18.2 Pfizer Inc Gammaretroviral Vector Description and Business Overview
6.18.3 Pfizer Inc Gammaretroviral Vector Sales, Revenue and Gross Margin (2018-2024)
6.18.4 Pfizer Inc Gammaretroviral Vector Product Portfolio
6.18.5 Pfizer Inc Recent Developments/Updates
6.19 Genezen
6.19.1 Genezen Corporation Information
6.19.2 Genezen Gammaretroviral Vector Description and Business Overview
6.19.3 Genezen Gammaretroviral Vector Sales, Revenue and Gross Margin (2018-2024)
6.19.4 Genezen Gammaretroviral Vector Product Portfolio
6.19.5 Genezen Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Gammaretroviral Vector Industry Chain Analysis
7.2 Gammaretroviral Vector Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Gammaretroviral Vector Production Mode & Process
7.4 Gammaretroviral Vector Sales and Marketing
7.4.1 Gammaretroviral Vector Sales Channels
7.4.2 Gammaretroviral Vector Distributors
7.5 Gammaretroviral Vector Customers
8 Gammaretroviral Vector Market Dynamics
8.1 Gammaretroviral Vector Industry Trends
8.2 Gammaretroviral Vector Market Drivers
8.3 Gammaretroviral Vector Market Challenges
8.4 Gammaretroviral Vector Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Gammaretroviral Vector Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Gammaretroviral Vector Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Gammaretroviral Vector Market Competitive Situation by Manufacturers in 2022
Table 4. Global Gammaretroviral Vector Sales (K Units) of Key Manufacturers (2018-2024)
Table 5. Global Gammaretroviral Vector Sales Market Share by Manufacturers (2018-2024)
Table 6. Global Gammaretroviral Vector Revenue (US$ Million) by Manufacturers (2018-2024)
Table 7. Global Gammaretroviral Vector Revenue Share by Manufacturers (2018-2024)
Table 8. Global Market Gammaretroviral Vector Average Price (US$/Unit) of Key Manufacturers (2018-2024)
Table 9. Global Key Players of Gammaretroviral Vector, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of Gammaretroviral Vector, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Gammaretroviral Vector, Product Type & Application
Table 12. Global Key Manufacturers of Gammaretroviral Vector, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Gammaretroviral Vector by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gammaretroviral Vector as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Gammaretroviral Vector Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Gammaretroviral Vector Sales by Region (2018-2024) & (K Units)
Table 18. Global Gammaretroviral Vector Sales Market Share by Region (2018-2024)
Table 19. Global Gammaretroviral Vector Sales by Region (2024-2029) & (K Units)
Table 20. Global Gammaretroviral Vector Sales Market Share by Region (2024-2029)
Table 21. Global Gammaretroviral Vector Revenue by Region (2018-2024) & (US$ Million)
Table 22. Global Gammaretroviral Vector Revenue Market Share by Region (2018-2024)
Table 23. Global Gammaretroviral Vector Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Gammaretroviral Vector Revenue Market Share by Region (2024-2029)
Table 25. North America Gammaretroviral Vector Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Gammaretroviral Vector Sales by Country (2018-2024) & (K Units)
Table 27. North America Gammaretroviral Vector Sales by Country (2024-2029) & (K Units)
Table 28. North America Gammaretroviral Vector Revenue by Country (2018-2024) & (US$ Million)
Table 29. North America Gammaretroviral Vector Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Gammaretroviral Vector Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Gammaretroviral Vector Sales by Country (2018-2024) & (K Units)
Table 32. Europe Gammaretroviral Vector Sales by Country (2024-2029) & (K Units)
Table 33. Europe Gammaretroviral Vector Revenue by Country (2018-2024) & (US$ Million)
Table 34. Europe Gammaretroviral Vector Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Gammaretroviral Vector Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Gammaretroviral Vector Sales by Region (2018-2024) & (K Units)
Table 37. Asia Pacific Gammaretroviral Vector Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Gammaretroviral Vector Revenue by Region (2018-2024) & (US$ Million)
Table 39. Asia Pacific Gammaretroviral Vector Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Gammaretroviral Vector Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Gammaretroviral Vector Sales by Country (2018-2024) & (K Units)
Table 42. Latin America Gammaretroviral Vector Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Gammaretroviral Vector Revenue by Country (2018-2024) & (US$ Million)
Table 44. Latin America Gammaretroviral Vector Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Gammaretroviral Vector Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Gammaretroviral Vector Sales by Country (2018-2024) & (K Units)
Table 47. Middle East & Africa Gammaretroviral Vector Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Gammaretroviral Vector Revenue by Country (2018-2024) & (US$ Million)
Table 49. Middle East & Africa Gammaretroviral Vector Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Gammaretroviral Vector Sales (K Units) by Type (2018-2024)
Table 51. Global Gammaretroviral Vector Sales (K Units) by Type (2024-2029)
Table 52. Global Gammaretroviral Vector Sales Market Share by Type (2018-2024)
Table 53. Global Gammaretroviral Vector Sales Market Share by Type (2024-2029)
Table 54. Global Gammaretroviral Vector Revenue (US$ Million) by Type (2018-2024)
Table 55. Global Gammaretroviral Vector Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Gammaretroviral Vector Revenue Market Share by Type (2018-2024)
Table 57. Global Gammaretroviral Vector Revenue Market Share by Type (2024-2029)
Table 58. Global Gammaretroviral Vector Price (US$/Unit) by Type (2018-2024)
Table 59. Global Gammaretroviral Vector Price (US$/Unit) by Type (2024-2029)
Table 60. Global Gammaretroviral Vector Sales (K Units) by Application (2018-2024)
Table 61. Global Gammaretroviral Vector Sales (K Units) by Application (2024-2029)
Table 62. Global Gammaretroviral Vector Sales Market Share by Application (2018-2024)
Table 63. Global Gammaretroviral Vector Sales Market Share by Application (2024-2029)
Table 64. Global Gammaretroviral Vector Revenue (US$ Million) by Application (2018-2024)
Table 65. Global Gammaretroviral Vector Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Gammaretroviral Vector Revenue Market Share by Application (2018-2024)
Table 67. Global Gammaretroviral Vector Revenue Market Share by Application (2024-2029)
Table 68. Global Gammaretroviral Vector Price (US$/Unit) by Application (2018-2024)
Table 69. Global Gammaretroviral Vector Price (US$/Unit) by Application (2024-2029)
Table 70. Novasep Corporation Information
Table 71. Novasep Description and Business Overview
Table 72. Novasep Gammaretroviral Vector Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 73. Novasep Gammaretroviral Vector Product
Table 74. Novasep Recent Developments/Updates
Table 75. MerckKGaA Corporation Information
Table 76. MerckKGaA Description and Business Overview
Table 77. MerckKGaA Gammaretroviral Vector Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 78. MerckKGaA Gammaretroviral Vector Product
Table 79. MerckKGaA Recent Developments/Updates
Table 80. Charles River Laboratories Corporation Information
Table 81. Charles River Laboratories Description and Business Overview
Table 82. Charles River Laboratories Gammaretroviral Vector Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 83. Charles River Laboratories Gammaretroviral Vector Product
Table 84. Charles River Laboratories Recent Developments/Updates
Table 85. UniQure N.V. Corporation Information
Table 86. UniQure N.V. Description and Business Overview
Table 87. UniQure N.V. Gammaretroviral Vector Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 88. UniQure N.V. Gammaretroviral Vector Product
Table 89. UniQure N.V. Recent Developments/Updates
Table 90. Waisman Biomanufacturing Corporation Information
Table 91. Waisman Biomanufacturing Description and Business Overview
Table 92. Waisman Biomanufacturing Gammaretroviral Vector Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 93. Waisman Biomanufacturing Gammaretroviral Vector Product
Table 94. Waisman Biomanufacturing Recent Developments/Updates
Table 95. Creative-Biogene Corporation Information
Table 96. Creative-Biogene Description and Business Overview
Table 97. Creative-Biogene Gammaretroviral Vector Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 98. Creative-Biogene Gammaretroviral Vector Product
Table 99. Creative-Biogene Recent Developments/Updates
Table 100. Aldevron Corporation Information
Table 101. Aldevron Description and Business Overview
Table 102. Aldevron Gammaretroviral Vector Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 103. Aldevron Gammaretroviral Vector Product
Table 104. Aldevron Recent Developments/Updates
Table 105. Addgene Corporation Information
Table 106. Addgene Description and Business Overview
Table 107. Addgene Gammaretroviral Vector Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 108. Addgene Gammaretroviral Vector Product
Table 109. Addgene Recent Developments/Updates
Table 110. Oxford Biomedica Corporation Information
Table 111. Oxford Biomedica Description and Business Overview
Table 112. Oxford Biomedica Gammaretroviral Vector Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 113. Oxford Biomedica Gammaretroviral Vector Product
Table 114. Oxford Biomedica Recent Developments/Updates
Table 115. Thermo Fisher Scientific Inc. Corporation Information
Table 116. Thermo Fisher Scientific Inc. Description and Business Overview
Table 117. Thermo Fisher Scientific Inc. Gammaretroviral Vector Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 118. Thermo Fisher Scientific Inc. Gammaretroviral Vector Product
Table 119. Thermo Fisher Scientific Inc. Recent Developments/Updates
Table 120. Fujifilm Corporation Corporation Information
Table 121. Fujifilm Corporation Description and Business Overview
Table 122. Fujifilm Corporation Gammaretroviral Vector Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 123. Fujifilm Corporation Gammaretroviral Vector Product
Table 124. Fujifilm Corporation Recent Developments/Updates
Table 125. Spark Therapeutics Inc Corporation Information
Table 126. Spark Therapeutics Inc Description and Business Overview
Table 127. Spark Therapeutics Inc Gammaretroviral Vector Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 128. Spark Therapeutics Inc Gammaretroviral Vector Product
Table 129. Spark Therapeutics Inc Recent Developments/Updates
Table 130. ABL Inc Corporation Information
Table 131. ABL Inc Description and Business Overview
Table 132. ABL Inc Gammaretroviral Vector Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 133. ABL Inc Gammaretroviral Vector Product
Table 134. ABL Inc Recent Developments/Updates
Table 135. Boehringer Ingelheim International GmbH Corporation Information
Table 136. Boehringer Ingelheim International GmbH Description and Business Overview
Table 137. Boehringer Ingelheim International GmbH Gammaretroviral Vector Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 138. Boehringer Ingelheim International GmbH Gammaretroviral Vector Product
Table 139. Boehringer Ingelheim International GmbH Recent Developments/Updates
Table 140. Brammer Bio Corporation Information
Table 141. Brammer Bio Description and Business Overview
Table 142. Brammer Bio Gammaretroviral Vector Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 143. Brammer Bio Gammaretroviral Vector Product
Table 144. Brammer Bio Recent Developments/Updates
Table 145. Creative Biogene Corporation Information
Table 146. Creative Biogene Description and Business Overview
Table 147. Creative Biogene Gammaretroviral Vector Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 148. Creative Biogene Gammaretroviral Vector Product
Table 149. Creative Biogene Recent Developments/Updates
Table 150. General Electric Corporation Information
Table 151. General Electric Description and Business Overview
Table 152. General Electric Gammaretroviral Vector Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 153. General Electric Gammaretroviral Vector Product
Table 154. General Electric Recent Developments/Updates
Table 155. Pfizer Inc Corporation Information
Table 156. Pfizer Inc Description and Business Overview
Table 157. Pfizer Inc Gammaretroviral Vector Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 158. Pfizer Inc Gammaretroviral Vector Product
Table 159. Pfizer Inc Recent Developments/Updates
Table 160. Genezen Corporation Information
Table 161. Genezen Description and Business Overview
Table 162. Genezen Gammaretroviral Vector Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 163. Genezen Gammaretroviral Vector Product
Table 164. Genezen Recent Developments/Updates
Table 165. Key Raw Materials Lists
Table 166. Raw Materials Key Suppliers Lists
Table 167. Gammaretroviral Vector Distributors List
Table 168. Gammaretroviral Vector Customers List
Table 169. Gammaretroviral Vector Market Trends
Table 170. Gammaretroviral Vector Market Drivers
Table 171. Gammaretroviral Vector Market Challenges
Table 172. Gammaretroviral Vector Market Restraints
Table 173. Research Programs/Design for This Report
Table 174. Key Data Information from Secondary Sources
Table 175. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Gammaretroviral Vector
Figure 2. Global Gammaretroviral Vector Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Gammaretroviral Vector Market Share by Type in 2022 & 2029
Figure 4. Lentiviral Vectors Product Picture
Figure 5. Adenoviral Vectors Product Picture
Figure 6. Adeno-Associated Viral Vectors Product Picture
Figure 7. Other Product Picture
Figure 8. Global Gammaretroviral Vector Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 9. Global Gammaretroviral Vector Market Share by Application in 2022 & 2029
Figure 10. Gene Therapy
Figure 11. Vaccinology
Figure 12. Other
Figure 13. Global Gammaretroviral Vector Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global Gammaretroviral Vector Market Size (2018-2029) & (US$ Million)
Figure 15. Global Gammaretroviral Vector Sales (2018-2029) & (K Units)
Figure 16. Global Gammaretroviral Vector Average Price (US$/Unit) & (2018-2029)
Figure 17. Gammaretroviral Vector Report Years Considered
Figure 18. Gammaretroviral Vector Sales Share by Manufacturers in 2022
Figure 19. Global Gammaretroviral Vector Revenue Share by Manufacturers in 2022
Figure 20. The Global 5 and 10 Largest Gammaretroviral Vector Players: Market Share by Revenue in 2022
Figure 21. Gammaretroviral Vector Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 22. Global Gammaretroviral Vector Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 23. North America Gammaretroviral Vector Sales Market Share by Country (2018-2029)
Figure 24. North America Gammaretroviral Vector Revenue Market Share by Country (2018-2029)
Figure 25. United States Gammaretroviral Vector Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 26. Canada Gammaretroviral Vector Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 27. Europe Gammaretroviral Vector Sales Market Share by Country (2018-2029)
Figure 28. Europe Gammaretroviral Vector Revenue Market Share by Country (2018-2029)
Figure 29. Germany Gammaretroviral Vector Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. France Gammaretroviral Vector Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. U.K. Gammaretroviral Vector Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Italy Gammaretroviral Vector Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. Russia Gammaretroviral Vector Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Asia Pacific Gammaretroviral Vector Sales Market Share by Region (2018-2029)
Figure 35. Asia Pacific Gammaretroviral Vector Revenue Market Share by Region (2018-2029)
Figure 36. China Gammaretroviral Vector Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. Japan Gammaretroviral Vector Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. South Korea Gammaretroviral Vector Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. India Gammaretroviral Vector Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Australia Gammaretroviral Vector Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. China Taiwan Gammaretroviral Vector Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Southeast Asia Gammaretroviral Vector Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Latin America Gammaretroviral Vector Sales Market Share by Country (2018-2029)
Figure 44. Latin America Gammaretroviral Vector Revenue Market Share by Country (2018-2029)
Figure 45. Mexico Gammaretroviral Vector Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Brazil Gammaretroviral Vector Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Argentina Gammaretroviral Vector Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Middle East & Africa Gammaretroviral Vector Sales Market Share by Country (2018-2029)
Figure 49. Middle East & Africa Gammaretroviral Vector Revenue Market Share by Country (2018-2029)
Figure 50. Turkey Gammaretroviral Vector Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. Saudi Arabia Gammaretroviral Vector Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. UAE Gammaretroviral Vector Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. Global Sales Market Share of Gammaretroviral Vector by Type (2018-2029)
Figure 54. Global Revenue Market Share of Gammaretroviral Vector by Type (2018-2029)
Figure 55. Global Gammaretroviral Vector Price (US$/Unit) by Type (2018-2029)
Figure 56. Global Sales Market Share of Gammaretroviral Vector by Application (2018-2029)
Figure 57. Global Revenue Market Share of Gammaretroviral Vector by Application (2018-2029)
Figure 58. Global Gammaretroviral Vector Price (US$/Unit) by Application (2018-2029)
Figure 59. Gammaretroviral Vector Value Chain
Figure 60. Gammaretroviral Vector Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed